showed a trendp = 0.09
REM-OSA showed a trend toward higher prevalence in the narcolepsy group compared to controls (26.4% vs 17.2%, OR: 1.73, 95% CI: 0.91–3.27, p = 0.09).
REM-OSA showed a trend toward higher prevalence in the narcolepsy group compared to controls (26.4% vs 17.2%, OR: 1.73, 95% CI: 0.91–3.27, p = 0.09).
The borderline non-significant REM-OSA difference (χ2=2.85, p =0.09; Cohen’s h =0.22) had ~83% post-hoc power, suggesting a potentially meaningful effect (9.2% prevalence difference) warranting validation in larger studies.
Comorbid conditions such as hypertension, diabetes mellitus, and bronchial asthma were more prevalent among patients with narcolepsy and OSA compared to those without, though these differences did not reach statistical significance ( Table 2 ).